Advance in microRNAs and epidermal growth factor receptor mutation on metastasis of non-small cell lung cancer
10.7507/1007-4848.201707030
- VernacularTitle:微小RNA和EGFR突变在非小细胞肺癌转移机制中的研究进展
- Author:
SHEN Cheng
1
;
ZHOU Kun
1
;
CHE Guowei
1
Author Information
1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
- Publication Type:Journal Article
- Keywords:
MicroRNA;
epidermal growth factor receptor;
non-small cell lung cancer;
metastasis
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2018;25(5):440-444
- CountryChina
- Language:Chinese
-
Abstract:
MicroRNA (miRNA) is a noncoding RNA and protein involved in regulating gene expression in the transcription level. Epidermal growth factor receptor (EGFR) is a protein tyrosine kinase receptor and its mutations have been confirmed in non-small cell lung cancer (NSCLC) by a large number of studies in recent years. EGFR tyrosine kinase inhibitor (EGFR-TKI) is widely used for treatment of NSCLC patients with EGFR mutation. In recent years, miRNA is more and more important in tumor metastasis. The role of EGFR mutations in NSCLC has become a hot spot as well. New researches report that the relationship between miRNA and EGFR mutations plays an important role in NSCLC metastasis. Therefore, we write this review to discuss the mechanisms of miRNA and EGFR mutations in metastasis of NSCLC.
